cladribine has been researched along with Adenocarcinoma, Endometrioid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, AM; Al-Haidose, A; Alharbi, A; Alhyassat, S; Carlus, FH; Carlus, SJ; Ganesh Kumar, A; Loganathan, L; Muthusamy, K; Sujatha, LB | 1 |
1 other study(ies) available for cladribine and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
An in silico analysis of the impact of POLE mutations on cladribine docking.
Topics: Carcinoma, Endometrioid; Cladribine; DNA Polymerase II; Exonucleases; Female; Humans; Molecular Docking Simulation; Mutation | 2022 |